A study evaluating 691 sporadic breast tumors, identified mutations affecting genes such as PIK3CA, FGFR2, TP53, and ERBB2, but no alterations in the ATM gene (Wilkerson et al. 2014). This evidence concerns the gene ERBB2 and breast neoplasm.